Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Gordon

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of Viral Hepatitis|August 19, 2014
APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS)E Teshale, M Lu, L B Rupp, et al.
Lancet (London, England)|October 5, 2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialM P Manns, J G McHutchison, S C Gordon, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.
The Journal of Social Psychology|September 12, 2000
A multicultural study of stereotyping in English-speaking countriesF T McAndrew, A Akande, R Bridgstock, et al.
Journal of Gastrointestinal Cancer|May 25, 2019
Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with CirrhosisWinston E Abara, P Spradling, Y Zhong, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy GroupJ G McHutchison, S C Gordon, E R Schiff, et al.
Hepatology (Baltimore, Md.)|August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CK L Lindsay, C Trepo, T Heintges, et al.
Hepatology (Baltimore, Md.)|February 1, 1997
Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trialD M Simon, S C Gordon, M M Kaplan, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2016
Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013P R Spradling, J Xing, L B Rupp, et al.
Journal of Viral Hepatitis|May 18, 2016
Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2013E H Teshale, J Xing, A Moorman, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of Viral Hepatitis|August 19, 2014
APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS)E Teshale, M Lu, L B Rupp, et al.
Lancet (London, England)|October 5, 2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialM P Manns, J G McHutchison, S C Gordon, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.
The Journal of Social Psychology|September 12, 2000
A multicultural study of stereotyping in English-speaking countriesF T McAndrew, A Akande, R Bridgstock, et al.
Journal of Gastrointestinal Cancer|May 25, 2019
Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with CirrhosisWinston E Abara, P Spradling, Y Zhong, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy GroupJ G McHutchison, S C Gordon, E R Schiff, et al.
Hepatology (Baltimore, Md.)|August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CK L Lindsay, C Trepo, T Heintges, et al.
Hepatology (Baltimore, Md.)|February 1, 1997
Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trialD M Simon, S C Gordon, M M Kaplan, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2016
Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013P R Spradling, J Xing, L B Rupp, et al.
Journal of Viral Hepatitis|May 18, 2016
Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2013E H Teshale, J Xing, A Moorman, et al.
Pageof 10